# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Reuters
- Reuters
- Reuters
Morgan Stanley analyst Patrick Wood downgrades Baxter Intl (NYSE:BAX) from Equal-Weight to Underweight and lowers the price ...
Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $38 to $37.
https://www.baxter.com/baxter-newsroom/baxter-issues-urgent-medical-device-recall-life2000-ventilator-due-potential
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt...